MedElevator
Войти в исследования Lasers in surgery and medicine · 2026
Laser Therapy in the Treatment of Scarring Secondary to Pyoderma Gangrenosum: A Case Series.
Клинический случайСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Vague Morgan, Shea Moira, Kumar Iksha, Onoday Heather, Ortega Loayza Alex G
Аннотация
OBJECTIVES: To evaluate the effectiveness of laser therapy, such as non-ablative fractional laser and pulse-dye laser therapy in reducing scar hypertrophy and erythema in patients with healed pyoderma gangrenosum lesions following successful control of systemic inflammation.
MATERIALS AND METHODS: A retrospective case series was conducted of six female patients who underwent non-ablative and pulse-dye laser therapy to treat scarring secondary to healed pyoderma gangrenosum lesions. Treatment courses varied by patient and are detailed in the full case descriptions. Clinical photographs and chart documentation were retrospectively reviewed to assess patient outcomes. The authors obtained written consent from patients for their photographs and medical information to be published in print and online, and with the understanding that this information may be publicly available.
RESULTS: All six patients demonstrated visible improvement in scar appearance, such as hypertrophy and erythema, documented by clinical examination and serial photography. Although no standardized assessment scales were applied, all patients reported subjective improvement in pain, texture, or appearance. No disease recurrence or signs of pathergy were observed following treatment.
CONCLUSION: This case series highlights the potential utility of non-ablative fractional laser and pulse-dye laser therapy to improve scar hypertrophy, pain, erythema, and appearance in healed pyoderma gangrenosum lesions. When initiated after systemic inflammatory disease is adequately controlled, the risk of pathergy appears minimized. Although larger studies are needed, this series highlights a promising approach to scar reduction in pyoderma gangrenosum.
MATERIALS AND METHODS: A retrospective case series was conducted of six female patients who underwent non-ablative and pulse-dye laser therapy to treat scarring secondary to healed pyoderma gangrenosum lesions. Treatment courses varied by patient and are detailed in the full case descriptions. Clinical photographs and chart documentation were retrospectively reviewed to assess patient outcomes. The authors obtained written consent from patients for their photographs and medical information to be published in print and online, and with the understanding that this information may be publicly available.
RESULTS: All six patients demonstrated visible improvement in scar appearance, such as hypertrophy and erythema, documented by clinical examination and serial photography. Although no standardized assessment scales were applied, all patients reported subjective improvement in pain, texture, or appearance. No disease recurrence or signs of pathergy were observed following treatment.
CONCLUSION: This case series highlights the potential utility of non-ablative fractional laser and pulse-dye laser therapy to improve scar hypertrophy, pain, erythema, and appearance in healed pyoderma gangrenosum lesions. When initiated after systemic inflammatory disease is adequately controlled, the risk of pathergy appears minimized. Although larger studies are needed, this series highlights a promising approach to scar reduction in pyoderma gangrenosum.